Sequoia Financial Advisors LLC Sells 3,252 Shares of Lam Research Corporation $LRCX

Sequoia Financial Advisors LLC reduced its stake in Lam Research Corporation (NASDAQ:LRCX) by 4.6% during the 2nd quarter, Holdings Channel.com reports. The firm owned 67,276 shares of the semiconductor company’s stock after selling 3,252 shares during the period. Sequoia Financial Advisors LLC’s holdings in Lam Research were worth $29,153,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of LRCX. Bayban bought a new stake in shares of Lam Research during the 4th quarter worth about $26,000. Vermillion Wealth Management Inc. bought a new position in Lam Research in the 1st quarter valued at about $26,000. Cedar Mountain Advisors LLC raised its holdings in Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 85 shares during the period. Paladin Partners LLC acquired a new stake in Lam Research during the second quarter worth approximately $26,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in Lam Research during the fourth quarter worth approximately $27,000. 84.61% of the stock is owned by institutional investors.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Analyst sentiment remains favorable, with Wall Street maintaining a consensus “Moderate Buy” view. Recent coverage also highlights Lam Research’s exposure to artificial intelligence, high-bandwidth memory and advanced DRAM investment, which could support demand for its semiconductor-manufacturing equipment. Consensus rating article Lam Research momentum article
• Positive Sentiment: Lam’s latest quarterly results exceeded expectations, with earnings per share of $1.82 versus the $1.69 consensus and revenue of $6.72 billion versus $6.66 billion. Revenue increased 30% year over year, and management’s next-quarter earnings guidance points to continued growth. These results underpin the long-term bullish case. Three reasons investors favor Lam Research
• Neutral Sentiment: Lam Research presented at Citi’s 2026 Global TMT Conference. The event could provide additional commentary on customer spending, AI-related demand and industry trends, but the supplied report does not identify a material new forecast or announcement. Citi conference transcript
• Negative Sentiment: The stock’s recent rise—nearly tripling over the past year and gaining about 45% in six months—has left investors vulnerable to profit-taking. With a high earnings multiple, even a normal market pullback or weaker risk appetite can pressure LRCX despite strong operating results. Lam Research larger market drop
• Negative Sentiment: Several articles describe clinical studies involving imaging, MRI or compression therapy. These items appear to be incorrectly associated with Lam Research and do not represent developments in the semiconductor-equipment company; investors should disregard them when assessing LRCX.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on LRCX shares. Mizuho reduced their price objective on Lam Research from $370.00 to $365.00 and set an “outperform” rating for the company in a report on Tuesday, August 25th. B. Riley Financial lowered their target price on Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. TD Cowen reissued a “buy” rating and set a $400.00 price target (up from $340.00) on shares of Lam Research in a report on Thursday, July 9th. Berenberg Bank set a $420.00 price target on Lam Research in a research note on Wednesday. Finally, UBS Group decreased their price objective on Lam Research from $435.00 to $425.00 and set a “buy” rating on the stock in a report on Tuesday, September 1st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $361.81.

Lam Research Stock Down 1.4%

Shares of LRCX opened at $315.84 on Thursday. Lam Research Corporation has a 12 month low of $104.61 and a 12 month high of $438.50. The firm’s 50 day moving average is $315.51 and its 200-day moving average is $293.41. The stock has a market capitalization of $395.22 billion, a PE ratio of 54.83, a P/E/G ratio of 1.27 and a beta of 1.85. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm’s revenue for the quarter was up 30.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts forecast that Lam Research Corporation will post 9.33 EPS for the current year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Shareholders of record on Wednesday, September 23rd will be issued a $0.33 dividend. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a yield of 0.4%. This is a boost from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s payout ratio is presently 18.06%.

Insiders Place Their Bets

In related news, insider Ava Harter sold 5,000 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $302.46, for a total value of $1,512,300.00. Following the completion of the transaction, the insider owned 42,462 shares of the company’s stock, valued at $12,843,056.52. The trade was a 10.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the company’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. This represents a 17.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.31% of the company’s stock.

Lam Research Profile

Lam Research Corporation is a semiconductor equipment company that develops and manufactures systems used in the fabrication of integrated circuits. Its equipment supports key wafer-processing steps, including deposition, etch, wafer cleaning, and related processes used to create and connect the microscopic features found on semiconductor devices.

The company serves semiconductor manufacturers producing a range of products, including memory, logic, and specialty chips. In addition to manufacturing equipment, Lam Research provides installation, maintenance, spare parts, upgrades, technical support, and other services intended to help customers operate and improve their fabrication facilities.

Founded in 1980, Lam Research is headquartered in Fremont, California, and serves customers through a global network of offices, engineering facilities, and support operations.